<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04051931</url>
  </required_header>
  <id_info>
    <org_study_id>2019-27</org_study_id>
    <nct_id>NCT04051931</nct_id>
  </id_info>
  <brief_title>The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients</brief_title>
  <official_title>The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pathophysiological characteristics of COPD is irreversible airflow restriction which may
      influence the gas exchange and cause the abnormal PaO2 and PaCO2. Assessment of the partial
      arterial pressure of carbon dioxide (PaCO2 ) is the 'gold standard' for the evaluation of the
      adequacy of alveolar ventilation.Method used mostly nowadays : arterial puncture which is
      accurate but is invasive 、painful、 non-dynamic and there is risk of infection and
      tissue、nerve damage. Noninvasive measurement methods (Most commonly used)： end-tidal CO2（
      ETCO2）、 transcutaneous CO2(TcCO2). They all can monitor the PaCO2 dynamically、 noninvasively,
      but is existence of controversy of the accuracy. So the investigators want to compare the
      accuracy of these two noninvasive methods for assessment of PaCO2.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 10, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>concordance between the values of PetCO2 and PaCO2 measured at the same time</measure>
    <time_frame>1 hour</time_frame>
    <description>concordance between the values of PetCO2 and PaCO2 measured at the same time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>concordance between the values of PtcO2 and PaCO2 measured at the same time</measure>
    <time_frame>1 hour</time_frame>
    <description>concordance between the values of PtcO2 and PaCO2 measured at the same time</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>stable COPD group</arm_group_label>
    <description>include COPD patients with stable state</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AECOPD group</arm_group_label>
    <description>include COPD patients with acute exacerbation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        stable and acute axcerbation COPD patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients

        Exclusion Criteria:

          -  hemodynamics is unstable;

          -  any other lung disease despite COPD；

          -  other diseases influencing experiments: Cognitive impairment disease、 mouth and nose
             trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shanshan Zha, master</last_name>
    <phone>15013023031</phone>
    <email>zhass2011@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rongchang Chen, master</last_name>
      <phone>020-83062882</phone>
      <email>zfhe_2019@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Guangzhou Medical University</investigator_affiliation>
    <investigator_full_name>Shanshan Zha</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

